Severe Cutaneous Reaction during Radiation Therapy with Concurrent Cetuximab
Authors:
- Wilfried BudachWBWilfried Budach
- Edwin BölkeEBEdwin Bölke
- Bernhard HomeyBHBernhard Homey
- 2 August 2007
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (5) , 514-515
Abstract
Cetuximab given concurrently with radiotherapy has recently been reported to result in a survival benefit for patients with locally advanced squamous-cell carcinoma of the head and neck, without increasing the toxic effects of radiotherapy.1 We report two cases of severe radiation dermatitis during the course of radiotherapy for squamous-cell carcinoma of the head and neck with concomitant use of cetuximab; these two cases of dermatitis occurred among five patients treated according to this protocol at our institution.Keywords
This publication has 2 references indexed in Scilit:
- Mechanisms of cutaneous toxicities to EGFR inhibitorsNature Reviews Cancer, 2006
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2006